www.gavi.org

THE GAVI 2016–2020 INVESTMENT OPPORTUNITY

Seth Berkley MD27 January 2015, Berlin

Reach every child

Worldwide, more than

30 vaccine doses

through routine

immunisation

programmes

are given

every second

Polio in the

endgame

Smallpox

eradicatedHealthier lives, stronger communities

Stronger economiesNo other intervention

touches so many lives.

Measles

95% reductionThe power of vaccines

Climbing coverage rates

Coverage rate (%) for the third dose of diphtheria-tetanus-pertussis vaccine (DTP)

* Based on data officially reported to WHO and UNICEF by current member states.

Note: Includes DTP-containing vaccines, such as pentavalent vaccine.

Source: WHO/UNICEF vaccine coverage estimates (July 2014).

Gavi-supported vaccination programmes:an overview

Refers to the first Gavi-supported introduction of each vaccine.

What we have achieved togetherin the past 15 years

500,000,000

7,000,000

children immunised

future deaths averted

Accelerate equitable

uptake and

coverage

of vaccines

Increase effectiveness &

efficiency of immunisation

delivery as integrated part of

health systems

Improve sustainability

of national immunisation

programmes

Shape markets

for vaccines and other

immunisation products

To save children’s lives

and protect people’s health

by increasing equitable use

of vaccines in lower-

income countries

Gavi strategy 2016–2020

Towards the fully protected child

Closing the immunisation gap

Vaccine coverage in Gavi-supported countries by

Coverage refers to the final dose of each vaccine, unless otherwise stated.

Sources: WHO/UNICEF coverage estimates and country official reported figures (MCV2 and rubella), as of

July 2013. 2015 and 2020 coverage: Gavi strategic demand forecast version 9.

Measles-containing vaccine1st dose

Pentavalent vaccine

Measles-containing vaccine2nd dose

Yellow fever vaccine a

Pneumococcal vaccine

Rotavirus vaccine

Rubella vaccine

HPV vaccine b

Coverage by vaccine (%)

200020152020

A broadening partnership…

Developing

country

governments

... and many others

across the public and

private spheres

civil society

private

sector

donor governments

vaccine

manufacturers

academia

Health workers

Supply chain

Financing

Data

National

immunisation

programmes

Polio

Measles

Other

Health systemsRoutine

CampaignNew

Traditional

Regional

Emergency

Campaigns

Outreach

Clinic

Vaccine

types

Delivery

modesSpecial

initiatives

Supporting an integrated approach to immunisation and health

Gavi’s resource mobilisation model

Market-shaping

Gavi secures lowest prices

2013 vaccine prices per dose (US$)

.

Gavi secures lowest prices

Source: UNICEF Supply Division, 2014

Cost to immunise a child with pentavalent,

pneumococcal and rotavirus vaccines continues to fall

Target =

reduction

Target =

reduction

Source: UNICEF Supply Division, 2014

Gavi secures lowest prices

Cost to immunise a child with pentavalent,

pneumococcal and rotavirus vaccines continues to fall

– but more needs to be done

-63%

-32%

-0.7%

A model for sustainability:co-financing and market shaping

Co-financing level(per dose)

Sustainability – beyond co-financing of new vaccines

Increasing domestic expenditure on immunisation

Source: Preliminary findings from Johns Hopkins and GVAP Steering Committee (2014), Costing,

Financing, Gap, and Return on Investment Analysis for Global Vaccine Action Plan (GVAP).

2011-2015

US$ 8 billion

2016-2020

US$ 12 billion

2011-2015

US$ 0.47 billion

2016-2020

US$ 1.2 billion

Gavi co-financing

Total domestic investments in immunisation

+250%

+50%

The Ask for 2016–2020

US$ 7.5 billion

additional funding

needed for immunisation

programmes through to 2020

(US$ billion)

IFFIm and other

assured resources

Total need

Accelerating impact

Sources: Gavi strategic demand forecasts 9 and 10,

Investing together for a healthy future: the 2016–2020 investment opportunity.

100 times

the number of

children born

in Germany

Every year, we will immunise

21

Our annual investments

will prevent

almost as

many deaths

as cancer

causes each year

in the EU

Gavi-supported programmes will protect and enable economic growth

G7 Official Development Assistance net investments

Gavi’seconomic impact

Sources:

Preliminary findings from Johns Hopkins and GVAP Steering

Committee (2014), Costing, Financing, Gap, and Return on

Investment Analysis for Global Vaccine Action Plan (GVAP)

OECD, 8 April 2014

2013:

US$ 95 bn

2016-2020:

US$ 80-100 bn

2016–2020 the projected peak of investments

(US$ billion)

Contributing to a better world

End all preventable

child and maternal deaths

End extreme

poverty

Reach and protect

all children with all vaccines

Ensure a world free of

vaccine-preventable diseases

www.gavi.org

THANK YOU